| __timestamp | Arrowhead Pharmaceuticals, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 52602000 |
| Thursday, January 1, 2015 | 382000 | 105812000 |
| Friday, January 1, 2016 | 158333 | 113485000 |
| Sunday, January 1, 2017 | 31407709 | 285461000 |
| Monday, January 1, 2018 | 16142321 | 141726000 |
| Tuesday, January 1, 2019 | 168795577 | 150446000 |
| Wednesday, January 1, 2020 | 87992066 | 224227000 |
| Friday, January 1, 2021 | 138287000 | 361897000 |
| Saturday, January 1, 2022 | 232810000 | 520812000 |
| Sunday, January 1, 2023 | 240735000 | 636892000 |
| Monday, January 1, 2024 | 3551000 | 855907000 |
Unleashing the power of data
In the dynamic world of biotechnology, Halozyme Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc. have showcased intriguing gross profit trends over the past decade. From 2014 to 2023, Halozyme's gross profit surged by over 1,100%, peaking at approximately $637 million in 2023. This remarkable growth reflects their strategic advancements in drug delivery technologies. Meanwhile, Arrowhead Pharmaceuticals experienced a more modest yet significant increase, with gross profits rising from a mere $175,000 in 2014 to around $240 million in 2023, marking a growth of over 137,000%. This growth underscores their expanding influence in RNA interference therapies. Notably, 2024 data for Halozyme is missing, leaving room for speculation on their future trajectory. These trends highlight the evolving landscape of biotech innovation, where strategic focus and technological advancements drive financial success.
Gross Profit Trends Compared: Merck & Co., Inc. vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Genmab A/S and Arrowhead Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or Halozyme Therapeutics, Inc.
Catalent, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Catalent, Inc. vs Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Alkermes plc
Halozyme Therapeutics, Inc. and Veracyte, Inc.: A Detailed Gross Profit Analysis
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends
Key Insights on Gross Profit: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.